Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.9 INR | -3.61% | -5.54% | -11.57% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 326.7 | 234.3 | 291.5 | 1,448 | 2,036 | 895.2 |
Enterprise Value (EV) 1 | 360.7 | 224.4 | 272.2 | 1,395 | 1,956 | 878.9 |
P/E ratio | -42.5 x | 7.31 x | 5.29 x | 13.8 x | 16.5 x | 17.9 x |
Yield | - | - | 3.96% | 0.8% | 0.57% | 1.29% |
Capitalization / Revenue | 0.89 x | 0.55 x | 0.51 x | 2.04 x | 2.69 x | 1.52 x |
EV / Revenue | 0.98 x | 0.53 x | 0.47 x | 1.97 x | 2.58 x | 1.49 x |
EV / EBITDA | 25.8 x | 3.8 x | 3 x | 9.47 x | 11.8 x | 13.1 x |
EV / FCF | 59.7 x | 6.02 x | 16.1 x | 92.1 x | 201 x | -12.5 x |
FCF Yield | 1.67% | 16.6% | 6.2% | 1.09% | 0.5% | -7.97% |
Price to Book | 1.4 x | 0.89 x | 0.95 x | 3.56 x | 3.93 x | 1.61 x |
Nbr of stocks (in thousands) | 11,544 | 11,544 | 11,544 | 11,544 | 11,544 | 11,544 |
Reference price 2 | 28.30 | 20.30 | 25.25 | 125.4 | 176.4 | 77.55 |
Announcement Date | 5/30/18 | 9/3/19 | 8/24/20 | 8/2/21 | 7/16/22 | 7/8/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 367.1 | 426.3 | 575.2 | 709 | 757.6 | 588.1 |
EBITDA 1 | 13.99 | 58.97 | 90.86 | 147.4 | 166 | 67.03 |
EBIT 1 | 2.523 | 49.9 | 81.69 | 138.8 | 150 | 53.46 |
Operating Margin | 0.69% | 11.71% | 14.2% | 19.57% | 19.8% | 9.09% |
Earnings before Tax (EBT) 1 | 0.3384 | 47.58 | 69.21 | 145.6 | 162.9 | 68.51 |
Net income 1 | -7.681 | 32.05 | 55.08 | 105.2 | 123.6 | 50.01 |
Net margin | -2.09% | 7.52% | 9.58% | 14.84% | 16.32% | 8.5% |
EPS 2 | -0.6654 | 2.776 | 4.771 | 9.117 | 10.71 | 4.332 |
Free Cash Flow 1 | 6.04 | 37.29 | 16.88 | 15.16 | 9.706 | -70.08 |
FCF margin | 1.65% | 8.75% | 2.93% | 2.14% | 1.28% | -11.92% |
FCF Conversion (EBITDA) | 43.19% | 63.23% | 18.58% | 10.28% | 5.85% | - |
FCF Conversion (Net income) | - | 116.35% | 30.65% | 14.4% | 7.85% | - |
Dividend per Share | - | - | 1.000 | 1.000 | 1.000 | 1.000 |
Announcement Date | 5/30/18 | 9/3/19 | 8/24/20 | 8/2/21 | 7/16/22 | 7/8/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 34 | - | - | - | - | - |
Net Cash position 1 | - | 9.98 | 19.2 | 52.3 | 80.2 | 16.4 |
Leverage (Debt/EBITDA) | 2.428 x | - | - | - | - | - |
Free Cash Flow 1 | 6.04 | 37.3 | 16.9 | 15.2 | 9.71 | -70.1 |
ROE (net income / shareholders' equity) | -3.25% | 12.9% | 19.3% | 29.6% | 26.7% | 9.31% |
ROA (Net income/ Total Assets) | 0.41% | 8.32% | 12.8% | 18.1% | 16.8% | 5.45% |
Assets 1 | -1,867 | 385.4 | 430.8 | 580.9 | 734.4 | 917.3 |
Book Value Per Share 2 | 20.20 | 22.90 | 26.40 | 35.20 | 44.90 | 48.20 |
Cash Flow per Share 2 | 0.0100 | 0.8700 | 1.670 | 4.500 | 1.960 | 0.6200 |
Capex 1 | 11.6 | 6.36 | 19.7 | 8.46 | 6.14 | 76 |
Capex / Sales | 3.15% | 1.49% | 3.42% | 1.19% | 0.81% | 12.93% |
Announcement Date | 5/30/18 | 9/3/19 | 8/24/20 | 8/2/21 | 7/16/22 | 7/8/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-11.57% | 14.26M | |
+4.06% | 49.8B | |
+22.04% | 42.65B | |
+27.43% | 26.61B | |
+10.94% | 19.29B | |
-1.61% | 16.7B | |
+6.48% | 15.94B | |
-11.69% | 15B | |
-23.40% | 14.43B | |
-17.88% | 14.12B |
- Stock Market
- Equities
- RESONANCE6 Stock
- Financials Resonance Specialties Limited